European Hematology Association
Westblaak 71
Rotterdam
3012 KE
Tel: 31-10-404-56-21
Fax: 31-10-436-18-17
Website: http://www.ecah.org/
Email: cme@ehaweb.org
188 articles about European Hematology Association
-
European Hematology Association: Multicenter Open-Label Phase 2 Study Of Ibrutinib In Chronic Graft Versus Host Disease (cGVHD) After Failure Of Corticosteroids
6/26/2017
-
European Hematology Association: Global Trial Of The Efficacy And Safety Of CTL019 In Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: An Interim Analysis Of The JULIET Study
6/26/2017
-
European Hematology Association: Early Metabolic Response Determination By FDG-PET Allows Substantial Reduction Of Chemotherapy And Its Toxicity In Patients With Advanced Stage Hodgkin Lymphoma: The GHSG HD18 Study
6/26/2017
-
European Hematology Association: Clinical And Biologic Covariates Of Outcomes In ZUMA-1: A Pivotal Trial Of Axicabtagene Ciloleucel (Axi-Cel; KTE-C19) In Patients With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)
6/26/2017
-
European Hematology Association: Bleeding Or Clotting In Elderly Patients With Cancer-Associated Venous Thromboembolism: Which Is Worse?
6/26/2017
-
AOP Orphan Pharmaceuticals AG And PharmaEssentiaAnnounce Latest Clinical Results For Ropeginterferon Alfa-2b In Polycythemia Vera From 3 Abstracts Presented At The 22nd Congress Of The European Hematology Association In Madrid
6/26/2017
-
Sunesis Announces Presentation Of Updated Results From Washington University-Sponsored Phase I/Cohort Expansion Trial Of Vosaroxin Plus Azacitidine In Patients With MDS At The European Hematology Association Annual Meeting
6/23/2017
-
Stemline Presents SL-401 Updated Stage 1 And 2 Data From Ongoing Pivotal Trial In BPDCN And Safety Experience Across Multiple Indications, Today At European Hematology Association
6/23/2017
-
Positive Phase Ib Data For NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, In Combination With Chemotherapy For Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Presented At The European Hematology Association Congress In Madrid, Spain
6/23/2017
-
Karyopharm Reports Updated Phase IIb SADAL Data For Selinexor In Diffuse Large B-Cell Lymphoma At The 2017 European Hematology Association Annual Meeting
6/23/2017
-
European Hematology Association: Two Is Better Than One: The Dual SYK/JAK Inhibitor Cerdulatinib Demonstrates Rapid Tumor Responses In A Phase II Study For Relapsed/Refractory NHL
6/23/2017
-
European Hematology Association: Treating Sickle Cell Disease And Beta-Thalassemia With CRISPR/Cas9 Gene Editing
6/23/2017
-
European Hematology Association: The More The T-Lymphocytes Differ, The More Effectively They Fight Against Leukemia
6/23/2017
-
European Hematology Association: Shedding New Light On The Prevention Of Platelet Storage Lesion
6/23/2017
-
European Hematology Association: Delayed Exposure To Common Infections Causes Acute Leukemia Of Childhood
6/23/2017
-
bluebird bio Presents New Data From HGB-205 Study Of LentiGlobin Drug Product In Patients With Transfusion-Dependent ?-Thalassemia (TDT) And Severe Sickle Cell Disease (SCD) At European Hematology Association Annual Meeting
6/23/2017
-
bluebird bio Announces Early Data From Phase III Northstar-2 (HGB-207) Study Of LentiGlobin Drug Product At European Hematology Association Annual Meeting
6/23/2017
-
Bellicum Reports Clinical Results Of BPX-501 In Pediatric Leukemias At The 22nd Congress Of The European Hematology Association
6/23/2017
-
Bellicum Announces Clinical Data On BPX-501 At Presidential Symposium Of The 22nd Congress Of The European Hematology Association
6/23/2017
-
ArQule Presents Preclinical Data For BTK Inhibitor, ARQ 531, At The 22nd Annual Congress Of European Hematology Association
6/23/2017